Mamoklam tablets 100mg, No. 40
Russian Pharmacy name:
Мамоклам таблетки 100мг, №40
Fibrocystic breast disease.
The drug Mamoklam is used orally before meals, a single dose - 1-2 tablets, 2-3 times a day at regular intervals during the day (daily dose of 3-6 tablets), the duration of the course of treatment is no more than one month.
If necessary, it is recommended to repeat the courses of treatment after a break of 2 weeks to 3 months.
| Coated tablets 100 mg, | 1 tab. |
| substance 'Klam' (in terms of dry matter) | not less than 0.1 g |
| lipids | not less than 0.04 g |
| iodine (in organically bound form) | not less than 0.1 mg |
| excipients: MCC; milk sugar; refined sugar; potato starch; Low molecular weight medical PVP; magnesium carbonate; calcium stearic acid; methylcellulose; titanium dioxide pigment grade A; twin 80; copper chlorophyll derivatives |
in dark glass jars of 20 or 30 pcs. or in polymer cans of 40 pcs .; in a pack of cardboard 1 can; or in a contour acheikova packing 10 or 20 pcs.; in a pack of cardboard 2 or 4 packages.
hypersensitivity to drug components;
kidney disease;
hyperfunction of the thyroid gland;
multinodular goiter;
thyrotoxicosis of various origins;
pregnancy;
period of breastfeeding.
Trade name : Mamoclam
Dosage form : Film-coated tablets.
Composition : Each tablet contains at least 0.1 g of the 'Laminaria' substance. Saponified concentrate 'in terms of dry matter, lipids - not less than 0.049 g, iodine - not less than 0.100 mg (iodine is contained in an organically bound form)
Excipients : microcrystalline cellulose, milk sugar, refined sugar, potato starch, low molecular weight medical polyvinylpyrrolidone, magnesium carbonate, calcium stearic acid, methylcellulose, titanium dioxide pigment grade A, tween - 80, copper chlorophyll derivatives.
Description : Biconvex film-coated tablets of light green color.
Pharmacological properties
Mamoklam has a therapeutic effect in fibrocystic mastopathy. Reduces the manifestations of mastalgia, leads to regression of cysts, normalizes the processes of proliferation of the epithelium of the mammary glands.
Indications for use
Treatment of fibrocystic mastopathy.
Contraindications
- hypersensitivity to the components of the drug;
- kidney disease;
- hyperfunction of the thyroid gland;
- multinodular goiter;
- thyrotoxicosis of various origins;
- pregnancy;
- the period of breastfeeding.
Dosage and administration The drug Mamoklam is administered orally before meals, a single dose - 1-2 tablets, 2-3 times a day at regular intervals during the day (daily dose of 3-6 tablets), the duration of the course of treatment is not more than one month.
If necessary, it is recommended to repeat the courses of treatment after a break of 2 weeks to 3 months.
Side effect
Allergic reactions, mainly in the form of itching, redness of the skin and skin rashes; heartburn; flatulence; diarrhea.
Interaction with other drugs
When using the drug Mamoklam in therapeutic doses, the body receives iodine in doses slightly higher than the recommended physiological dose of this microelement, and therefore, Mamoklam should not be used with drugs containing iodine.
Overdose
No overdose phenomena have been identified when using Mamoklam.
Release form
Tablets of 0.1 g, coated:
10, 20 tablets in a blister;
20.30 tablets in an orange glass jar;
40 tablets in a polymer jar.
Storage conditions
The drug is stored in a dry, dark place and out of reach of children at a temperature of 5 to 20 ? C
Shelf life is
2 years.
Do not use after the expiration date indicated on the package.
Terms of dispensing from pharmacies
Without a doctor's prescription.